Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
The Australia Precision Medicine market was valued at USD 4.89 Billion in 2025 and is expected to grow at a CAGR of 9.70%, reaching USD 12.34 Billion by 2035. The market growth is driven by the increasing integration of genomic medicine into clinical care, supported by government investment in genomics research, expanding pharmacogenomic applications, growing adoption of biomarker-guided cancer treatment, and the development of national frameworks to embed genomic testing and personalized treatment across the healthcare system.
Key Market Trends and Insights
- By technology, Next generation sequencing or NGS is expected to lead during the forecast period.
- By application, oncology is expected to lead, accounting 89.04% of market share in the historical period.
- By end-user, hospitals and clinics are expected to lead during the forecast period.
Market Size and Forecast
- Market Size (2025): USD 4.89 Billion
- Projected Market Size (2035): USD 12.34 Billion
- CAGR (2026-2035): 9.70%
Compound Annual Growth Rate
9.7%
Value in USD Billion
2026-2035
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Australia Precision Medicine Market Overview
The Australia Precision Medicine Market encompasses a comprehensive range of genomic sequencing technologies, molecular diagnostics, biomarker testing, companion diagnostics, bioinformatics, artificial intelligence and machine learning platforms, proteomics, metabolomics, transcriptomics, and specialized services supporting personalized disease diagnosis and treatment. Precision medicine enables targeted therapy selection, molecular disease profiling, pharmacogenomic assessment, early diagnosis, and individualized patient management across oncology and other therapeutic areas. The market was valued at USD 4.89 Billion in 2025, supported by increasing adoption of genomic medicine, growing demand for biomarker-guided therapies, expansion of precision oncology, government investment in genomics research and clinical integration, rising use of next-generation sequencing, and technological advances in bioinformatics, molecular diagnostics, and AI-enabled clinical decision-making.
Australia Precision Medicine Market Growth Analysis and Key Influencers
|
Analysis Type |
Factors |
Example |
|
Market Drivers |
Growing integration of genomic testing into Australian healthcare is accelerating precision diagnosis, biomarker-guided treatment, pharmacogenomics, and individualized patient management across major diseases. |
Australia’s Genomics Health Futures Mission supports research translating genomic discoveries into clinical applications, strengthening adoption of precision medicine across healthcare settings. |
|
Market Restraints |
High testing costs, unequal access to specialized genomic services, workforce shortages, and complex reimbursement pathways can constrain broader adoption of precision medicine. |
Limited availability of specialized genomic testing outside major metropolitan centers can delay testing and create geographic disparities in access to precision healthcare. |
|
Market Opportunities |
Increasing availability of molecular biomarkers and targeted therapies creates opportunities for precision oncology, companion diagnostics, liquid biopsy, and genomic profiling services across Australia. |
Broader genomic profiling of tumors can identify actionable alterations, enabling Australian clinicians to match patients with targeted therapies and relevant clinical trials. |
Australia Precision Medicine Market Dynamics
The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.
Australia Precision Medicine Market Growth Drivers
National Genomic Integration Strengthening the Market Value
Australia’s policy environment is increasingly converting genomic research into clinical infrastructure. According to the Australian Government, the National Health Genomics Policy Framework 2026-30, released in September 2026, is designed to embed genomics nationally, while Genomics Australia coordinates implementation. This policy standardization should reduce fragmentation and improve investment visibility, supporting sustained demand for sequencing, bioinformatics and clinical genomic services.
Australia Precision Medicine Market Restraints
Implementation Costs and Uneven Access Constrain Broader Precision Medicine Adoption
As per Luisa Clucas et al., 2025, implementing genomic medicine in Australian hospitals requires substantial workforce, governance, infrastructure, and workflow resources. A separate Australian budget-impact analysis found genomic-testing uptake below diffusion-modelled trajectories, highlighting funding and implementation friction. These constraints can lengthen procurement cycles and weaken near-term returns on genomic infrastructure, particularly where reimbursement and specialist capacity remain uneven.
Australia Precision Medicine Market Opportunities
Investment in Genomic Infrastructure Creates Opportunities for Precision Medicine Expansion
Australia’s precision-oncology ecosystem is expanding through both public investment and private-sector infrastructure. As per the Australian Government, 2025 funding extended ZERO and PrOSPeCT, while in August 2026 Novogene announced Australia’s first private-hospital co-located genomics laboratory with Cabrini. Such investment can shorten testing pathways and deepen sequencing capacity, improving capital productivity and creating opportunities for oncology diagnostics, multi-omics, and biomarker-led treatment services.
Australia Precision Medicine Market Trends
Comprehensive Genomic Profiling Is Moving Toward Routine Clinical Integration in Australia
Australia’s most important precision-medicine trend is the transition of comprehensive genomic profiling from specialist testing toward routine clinical care, particularly oncology. According to the Australian Government, the 2026-30 National Health Genomics Policy Framework is designed to embed genomics across the health system, while Cabrini and Novogene announced Australia’s first private-hospital co-located genomics laboratory in August 2026. This convergence of policy, clinical infrastructure and private investment should improve testing capacity, shorten diagnostic pathways and support more capital-efficient deployment of sequencing and multi-omics technologies.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Australia Precision Medicine Market Share
Oncology is Expected to Lead the Market Share by Application
Oncology therapeutics is the leading application in Australia’s precision medicine market, supported by rapid integration of genomic profiling into cancer diagnosis, treatment selection and clinical trials. According to the Australian Government, 2025 funding extended ZERO and PrOSPeCT, expanding access to molecularly guided treatment for Australian cancer patients. In 2026, Genomics Australia identified personalized cancer care as an initial national priority. This institutional alignment is strengthening demand for sequencing, biomarker testing and companion diagnostics while improving the commercial scalability of precision-oncology infrastructure.
Leading Players in the Australia Precision Medicine Market
The key features of the market report include patent analysis, funding and investment analysis, and strategic initiatives by leading players. The major companies in the market are as follows:
F. Hoffmann-La Roche AG:
Roche is a Switzerland-based healthcare company operating across pharmaceuticals and diagnostics, with substantial capabilities in precision medicine, molecular diagnostics, oncology, immunology and neuroscience. Its portfolio includes targeted therapies, companion diagnostics, sequencing technologies and digital health solutions, supporting biomarker-driven disease management and personalised treatment across major clinical applications.
Thermo Fisher Scientific:
Thermo Fisher Scientific provides analytical instruments, laboratory technologies, reagents, consumables and specialised services supporting precision medicine research and clinical applications. Its portfolio spans next-generation sequencing, molecular diagnostics, genetic analysis, proteomics and laboratory informatics. The company serves pharmaceutical, biotechnology, academic, clinical and research customers across international markets
QIAGEN N.V.:
QIAGEN develops molecular diagnostics, sample technologies, bioinformatics and molecular testing solutions used across research and clinical settings. Its precision medicine portfolio includes companion diagnostic technologies, nucleic-acid extraction, PCR-based assays, sequencing-related workflows and digital analysis tools. The company supports oncology, infectious disease, hereditary disease and other molecular testing applications globally.
Novartis AG:
Novartis is a global pharmaceutical company focused on innovative medicines across cardiovascular, immunology, neuroscience and oncology-related therapeutic areas. Its precision medicine activities incorporate molecular biomarkers, genetic insights and targeted treatment strategies. The company has developed therapies and clinical-development programs designed around defined patient populations and disease-specific biological characteristics.
Other key players include Pfizer, Inc., Biogen Inc., AstraZeneca Plc, GE Healthcare, Bristol Myers Squibb, Amgen Inc.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Australia Precision Medicine Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Technology
- Big Data Analytics
- Bioinformatics
- Next-Generation Sequencing (NGS)
- AI & Machine Learning
- Companion Diagnostics
- Genomics
- Proteomics
- Metabolomics
- Epigenomics
- Transcriptomics
Australia’s precision medicine ecosystem is supported by the convergence of genomic sequencing, computational biology and data-driven clinical decision-making. NGS, genomics and bioinformatics underpin molecular profiling, while AI and machine learning increasingly support interpretation of complex datasets. Companion diagnostics, proteomics, metabolomics, epigenomics and transcriptomics extend precision approaches beyond conventional genomic testing.
Market Breakup by Application
- Oncology
- Neurology
- Hematology
- Respiratory
- Immunology
- Rare Genetic Disorders
- Metabolic Disorders
- Others
Precision medicine applications in Australia span oncology and several non-oncological therapeutic areas. Oncology remains a major application because molecular profiling and biomarker-directed treatment are increasingly incorporated into cancer management. Neurological, hematological, respiratory, immunological, rare genetic and metabolic disorders also provide important applications, particularly where genomic or molecular heterogeneity influences diagnosis or treatment selection.
Market Breakup by End User
- Hospital and Clinics
- Clinical Laboratories
- Pharmaceutical & Biotechnology Companies
- Contract Research Organisations (CROs)
- Healthcare IT & Bioinformatics Firms
- Research and Academic Institutes
- Homecare Settings
- Others
Australia’s precision medicine ecosystem serves clinical, laboratory, pharmaceutical and research settings. Hospitals and clinics and clinical laboratories constitute important points of genomic testing and interpretation, while pharmaceutical and biotechnology companies use precision approaches for drug development and biomarker discovery. CROs, healthcare IT firms, academic institutes and homecare settings support complementary research, analytical and clinical activities.
Key Questions Answered in the Australia Precision Medicine Market Report
- What was the Australia Precision Medicine market value in 2025?
- What is the Australia Precision Medicine market forecast outlook for 2026-2035?
- What are the major factors aiding the Australia Precision Medicine market demand?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major Australia Precision Medicine market trends?
- Which technology is expected to dominate the market segment?
- Which application is projected to lead the market segment?
- Which end user is likely to dominate the market segment?
- Who are the key players involved in the Australia Precision Medicine market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Pricing Plans
Upto 15% Off
USD
-
$1999 $1799
-
$3099 $2789
-
$4599 $3909
-
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
